---
schema_version: "secwatch.filing_event.v1"
accession: "0001459839-26-000066"
form_type: "8-K"
ticker: "SIBN"
cik: "0001459839"
company_name: "SI-BONE, Inc."
filed_at: "2026-08-03T20:11:12+00:00"
generated_at: "2026-08-03T20:12:07.653130+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# SI-BONE Q2 revenue up 15.2% to $56.0M; raises FY 2026 revenue guidance to $231M-$233M

## Summary
- Net loss improved 33.6% to $4.1M ($0.09 loss per share) vs $6.2M loss a year ago.
- Adjusted EBITDA positive at $2.8M, up 178% from $1.0M in Q2 2025.
- U.S. revenue $53.2M (+14.7%); active U.S. physician base grew 19% to 1,715.
- FY 2026 revenue guidance raised to $231M-$233M (15-16% growth); operating expense growth lowered to ~12%.
- Cash and equivalents $145.9M; positive cash from operations of $0.8M in Q2.

## SEC filing metadata
- accession: 0001459839-26-000066
- form_type: 8-K
- ticker: SIBN
- cik: 0001459839
- company_name: SI-BONE, Inc.
- filed_at: 2026-08-03T20:11:12+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1459839/000145983926000066/0001459839-26-000066-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1459839/000145983926000066/sibn-20260803.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001459839-26-000066
- JSON: https://secwatch.observer/filing/0001459839-26-000066.json
- Plain text: https://secwatch.observer/filing/0001459839-26-000066.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.